Gotrin 0.125mg Injection

Overview Gotrin 0.125mg Injection

Uterine bleeding following childbirth or termination of pregnancy may be managed with a 0.125mg injection of Gotrin. This medication acts on uterine smooth muscle, enhancing contractility (tone, frequency, and strength of contractions), thereby minimizing blood loss. Administration is strictly by a physician in a hospital setting via intravenous or intramuscular injection; self-administration is prohibited. Dosage and frequency are determined by the treating physician based on individual needs and the specific indication. The physician will adjust the dose to optimize symptom control. Headache, elevated blood pressure, and seizures are potential side effects; patients should report any concerning or persistent symptoms. Strategies to mitigate or prevent side effects may be available. Alcohol consumption should be avoided during treatment. Prior to initiating Gotrin therapy, patients should inform their physician of any pre-existing conditions such as heart disease or hypertension, and provide a complete list of all other medications being taken, as potential drug interactions may compromise efficacy or alter the drug's action.

Uses of Gotrin 0.125mg Injection

Hemorrhage postpartum

Major Benefits of Gotrin 0.125mg Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Gotrin 0.125mg Injection:

• High blood pressure
• Headache
• Seizure

How to use Gotrin 0.125mg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Gotrin 0.125mg Injection works:

Ergotamine tartrate injection (0.125mg) is an ergot derivative that induces prolonged uterine smooth muscle contractions. This vasoconstriction effectively reduces postpartum hemorrhage.

What if you forget to take Gotrin 0.125mg Injection :

NA